Download PDF
1 / Pages

Other users also viewed these articles

Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis Ichiro Yoshii; Tatsumi Chijiwa; Naoya Sawada;
Reumatol Clin. 2022;18:574-9
Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting Sara Marsal Barril; Mª Auxiliadora Martin-Martinez; Francisco Javier Blanco-Garcia; Antonio Fernández-Nebro; Rosario García de Vicuña; Jesús Tornero-Molina; Fernando Sánchez-Alonso; Marta Novella-Navarro; Alejandro Escudero-Contreras; Juan José Alegre-Sancho; Ana Urruticoechea-Arana; Maria Sagrario Bustabad-Reyes; Pilar Trenor-Larraz; Trinidad Pérez-Sandoval; Maria Isabel Tevar-Sánchez; Jesús T. Sánchez-Costa; Enrique Raya-Álvarez;
Reumatol Clin. 2022;18:567-73
Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018 Mario H. Cardiel; Sandra Carrillo; Marcela Pérez; Lilia Andrade; César Pacheco Tena; Luis H. Silveira; Leonardo Limón; Sergio Cerpa; Sergio Gutiérrez Ureña; Sergio Durán; Fedra Irazoque Palazuelos; Sandra Muñoz López; Sandra Araceli Sicsik Ayala; Leonor Barile; María Azucena Ramos Sánchez; Daniel Grajeda Portes; Margarita Portela; Alina Hernández Bedolla; José Luis García-Figueroa; Mauricio Montero; Carlos Abud-Mendoza; Marco Ulises Martínez Martínez; David Herrera van Ostdam; Virginia Pascual-Ramos; Javier Merayo-Chalico; Istar Guzmán-Sánchez; María Esther Pérez-Bastidas; Jorge Enrique Aguilar Arreola; Alejandra López Rodríguez; Greta Reyes-Cordero; Humberto Alfredo Ricardez; María Fernanda Hernández Cabrera; Guadalupe Olvera-Soto; Daniel Xibillé Friedmann;
Reumatol Clin. 2021;17:215-28